| __timestamp | Agios Pharmaceuticals, Inc. | Geron Corporation |
|---|---|---|
| Wednesday, January 1, 2014 | 100371000 | 8901000 |
| Thursday, January 1, 2015 | 141827000 | 9574000 |
| Friday, January 1, 2016 | 220163000 | 14695000 |
| Sunday, January 1, 2017 | 292681000 | 8437000 |
| Monday, January 1, 2018 | 1397000 | 12723000 |
| Tuesday, January 1, 2019 | 1317000 | 51272000 |
| Wednesday, January 1, 2020 | 2805000 | 50052000 |
| Friday, January 1, 2021 | 18777000 | 783000 |
| Saturday, January 1, 2022 | 1704000 | 868000 |
| Sunday, January 1, 2023 | 9504000 | 123740000 |
| Monday, January 1, 2024 | 4165000 |
Unleashing the power of data
In the competitive landscape of biotechnology, cost efficiency is a critical factor for success. This analysis delves into the cost of revenue trends for Agios Pharmaceuticals, Inc. and Geron Corporation from 2014 to 2023. Agios Pharmaceuticals initially led with a cost of revenue peaking in 2017, but experienced a dramatic 99% decrease by 2018. In contrast, Geron Corporation maintained a more stable trajectory, with a notable spike in 2023, reaching its highest cost of revenue. This suggests a strategic shift or increased operational costs. Over the decade, Agios showed a 90% reduction in cost of revenue, while Geron saw a 1,300% increase. These trends highlight the dynamic nature of financial strategies in the biotech sector, where companies must balance innovation with cost management to thrive.
Takeda Pharmaceutical Company Limited vs Geron Corporation: Efficiency in Cost of Revenue Explored
Cost of Revenue Comparison: Intra-Cellular Therapies, Inc. vs Agios Pharmaceuticals, Inc.
Comparing Cost of Revenue Efficiency: Intra-Cellular Therapies, Inc. vs Geron Corporation
Bio-Techne Corporation vs Agios Pharmaceuticals, Inc.: Efficiency in Cost of Revenue Explored
Walgreens Boots Alliance, Inc. vs Geron Corporation: Efficiency in Cost of Revenue Explored
Cost Insights: Breaking Down Halozyme Therapeutics, Inc. and Agios Pharmaceuticals, Inc.'s Expenses
Comparing Cost of Revenue Efficiency: Pharming Group N.V. vs Agios Pharmaceuticals, Inc.
Vericel Corporation vs Geron Corporation: Efficiency in Cost of Revenue Explored
Agios Pharmaceuticals, Inc. vs Iovance Biotherapeutics, Inc.: Efficiency in Cost of Revenue Explored
Breaking Down SG&A Expenses: Agios Pharmaceuticals, Inc. vs Geron Corporation
Cost of Revenue Comparison: Geron Corporation vs Travere Therapeutics, Inc.